Abstract: Provided is a novel class of solid water-dispersible powders, including a plurality of water-insoluble photoinitiators in nanoparticle forms for use in water-based ink formulations.

Abstract: A product design and process design device includes: a storage unit that stores design specification information containing the tolerance of a dimensional variation at any site of an assembly product, part dimension error information, assembly facility error information, assembly tolerance information, the part dimension error information, and the assembly facility error information, part manufacturing cost information, and facility investment cost information with respect to the assembly facility error information; a tolerance distribution processing unit that uses the assembly tolerance information to generate proposed tolerance distributions that differ in distributional combination with respect to each error, and calculates part manufacturing costs and facility investment costs; a facility planning processing unit that determines a proposed tolerance distribution, with, as an evaluation index, total production costs respectively including the sums of the part manufacturing costs and the facility investmen

Abstract: The present invention provides therapeutic formulations, including therapeutic nanoemulsions, and related methods for the in vivo delivery of hydrophobic compounds, including an important class of hydrophobic anesthetics. Formulations and methods of the invention include semifluorinated block copolymers and perhalogenated fluorous compounds, such as perfluorooctyl bromide or perfluorodecalin, capable of forming a stable nanoemulsion without the need of conventional lipid components that support bacterial and/or fungal growth (e.g., soybean oil and similar lipids). In certain embodiments, emulsion-based formulations are provided that are capable of formulating, delivering and releasing amounts of hydrophobic drugs effective for a range of clinical applications, including inducing and maintaining anesthesia in patients.

Abstract: A composite material is provided including a polymer matrix and undercooled liquid metallic core-shell particles disposed in the matrix, wherein the particles each have an outer shell and a liquid metallic material as a core contained within the outer shell. The outer shell is frangible such that the liquid metallic material is released from at least some of the particles in response to a mechanical load applied to the composite and solidifies in-situ in the polymer matrix. As a result, the composite material can be self-strengthening and self-healing and can be reconfigurable in shape at ambient temperature.

Abstract: Embodiments of the present invention comprises apparatuses and methods of measuring levels of neurological impairment. Certain embodiments of the invention comprise a headset that emits light into the user's eyes and the system tracks the pupils' orientation, movement, contraction and dilation. In specific embodiments, the headset can run a battery of tests and calculate a score indicating the user's level of neurological impairment.

Abstract: A substrate support for a substrate processing system includes a plurality of heating zones, a baseplate, at least one of a heating layer and a ceramic layer arranged on the baseplate, and a plurality of heating elements provided within the at least one of the heating layer and the ceramic layer. The plurality of heating elements includes a first material having a first electrical resistance. Wiring is provided through the baseplate in a first zone of the plurality of heating zones. An electrical connection is routed from the wiring in the first zone to a first heating element of the plurality of heating elements. The first heating element is arranged in a second zone of the plurality of heating zones and the electrical connection includes a second material having a second electrical resistance that is less than the first electrical resistance.

Abstract: The present invention relates to a method for producing astrocytes comprising obtaining neural progenitor cells from stem cells so as to continuously produce astrocytes with high purity and same traits, followed by two steps of differentiating the neural progenitor cells into the astrocytes, and astrocytes produced therefrom. Since the method of preparing the astrocytes provided in the present invention enables not only production of the astrocytes with high purity and faster production of the astrocytes with same characteristics, but also rapid differentiation of the astrocytes using the neural progenitor cells when necessary, it can be widely used for effectively treating a patient with a disease which requires transplantation of the astrocytes.

Abstract: A network interface controller for a communication network of a substrate processing system includes a data collection module configured to monitor a communication bus to retrieve and store data frames transmitted between components of the substrate processing system. A user interface is configured to receive inputs for configuring extraction of data from the data frames. A data processing module is configured to store, based on a network configuration file, a map correlating data within the data frames to of the components of the substrate processing system, extract data from the data frames in accordance with the inputs received by the user interface and the map, and provide, to the user interface, the data as extracted from the data frames. The user interface is further configured to display the data as extracted from the data frames in accordance with the inputs received by the user interface.

Abstract: A decontamination method that includes the steps of decontaminating an object containing radioactive contaminated metals or alloys with a chemical decontamination agent including sulfuric acid (H2SO4) and forming a Ba or Sr precipitate by adding a Ba or Sr cation and a hydroxylion or halogen anion salts to the decontamination waste water.

Abstract: The present invention relates to a novel phenonthroline based pincer complexes and process for preparation thereof. The present invention also provides a one pot process for the conversion of carbon dioxide to methanol in the presence of a molecularly defined pincer-type single-site Ru-catalyst and secondary amine. Further the present invention provides the use of phenonthroline based pincer complexes for the esterification of alcohols and hydrogenation of esters under mild conditions.

Abstract: A tunnel field-effect transistor (TFET) includes a fin, an insulator layer, and at least one gate. The fin has a doped first region, a doped second region, and an interior region between the first region and the second region. The interior region is undoped or is more lightly doped than the first region and the second region. At least the interior region of the fin formed as a type II superlattice, wherein materials of the superlattice alternate vertically. The insulator layer is formed around the interior region. The gate is formed on at least a portion of the insulator region. The insulator layer and the at least one gate are configured to generate an inhomogeneous electrostatic potential within the interior region.

Abstract: An embodiment of the inventive concept includes an optical signal generating circuit, a controlling circuit, a waveform shaping circuit, and an output circuit. The optical signal generating circuit generates a first optical signal including pulses. The controlling circuit generates a control signal indicating a first pulse to be attenuated in magnitude among the pulses. The waveform shaping circuit attenuates a magnitude of the first pulse based on the control signal and the first optical signal, and generates a second optical signal including pulses corresponding to the pulses included in the first optical signal and the first pulse having the attenuated magnitude. The output circuit outputs an electric signal of bands corresponding to differences between frequencies of the pulses included in the second optical signal based on the second optical signal. A band corresponding to the first pulse among the bands of the electric signal is adjusted as the magnitude of the first pulse is attenuated.

Abstract: Methods and apparatus for performing high energy atomic layer etching are provided herein. Methods include providing a substrate having a material to be etched, exposing a surface of the material to a modification gas to modify the surface and form a modified surface, and exposing the modified surface to an energetic particle to preferentially remove the modified surface relative to an underlying unmodified surface where the energetic particle has an ion energy sufficient to overcome an average surface binding energy of the underlying unmodified surface. The energy of the energetic particle used is very high; in some cases, the power applied to a bias used when exposing the modified surface to the energetic particle is at least 150 eV.

Abstract: The present disclosure relates to a particle including at least one atomic-scale channel formed on a surface of the particle or on a surface and inside of the particle; a catalyst including the particle, particularly a catalyst for efficient and selective electrochemical conversion of carbon dioxide into high value-added C2+ fuel; and a method of preparing the particle.

Abstract: The present invention provides a solid-phase catalyst for decomposing hydrogen peroxide comprising a permanganate salt and a manganese (II) salt. The solid-phase catalyst stays a solid state in the form of nanoparticles at the time of hydrogen peroxide decomposition, and thus can be recovered for reuse and also has an excellent decomposition rate. In the method for producing a solid-phase catalyst for decomposing hydrogen peroxide according to the present invention, a solid-phase catalyst is produced from a solution containing a permanganate salt, a manganese (II) salt, and an organic acid, so that the produced solid-phase catalyst is precipitated as a solid component even after a catalytic reaction, and thus is reusable and environmentally friendly, and cost reduction can be achieved through the simplification of a catalyst production technique.

Abstract: The present invention relates to series of compounds as an inhibitor targeting Proliferating Cell Nuclear Antigen (PCNA). Pharmaceutical compositions of those compounds and methods of using them in the treatment of cancer are within the scope of this disclosure.

Abstract: The present invention relates to a method for controlling a structural member design considering constructability of formwork, comprising: an initial input step S10 wherein drawing information including structural member information is inputted from an input unit; a recognition step S20 wherein space information and structural members are recognized from the drawing information; a space partitioning step S30 wherein arrangement spaces in which previously set standard forms are arranged are determined; a form arrangement step S40 wherein the previously set standard forms are virtually arranged; a coordinate determination step S50 wherein the coordinate positions of the previously set standard forms are recognized; and an optimization step S60 wherein the variable information of the structural members is changed.

Abstract: Provided herein is a three-dimensional co-culture of adipocytes and macrophages, wherein, in a hydrogel scaffold containing adipocytes and macrophages, the adipocytes and the macrophages are co-cultured to form a fat-like tissue, which can be then utilized in the studies and medicine development for treating metastatic diseases associated with adipose tissue.

Abstract: A method of preparing silicon carbide according to the present invention includes reacting a silicon-containing compound with carbon dioxide, wherein a reducing agent is optionally used.

Abstract: A number of devices and methods for biopassivating explosive ordnance are disclosed. In some embodiments, a biopassivation reactor device is used to render energetic material in an explosive ordnance less explosive and/or non-explosive. This can be done by coupling the biopassivation reactor device to the fuse opening of the explosive ordnance. This can also be done by incorporating the biopassivation reactor device into the explosive ordnance at the time of manufacture. The biopassivation reactor device can include a housing enclosing microorganisms, water, additives, and/or the like. In some embodiments, an entire ordnance magazine can be operated as a bioreactor to passivate the explosive ordnance inside.